Loading...
Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension
BACKGROUND: Treprostinil is a prostacyclin analogue that directly vasodilates pulmonary and systemic arterial vascular beds. The United States Food and Drug Administration approved inhaled treprostinil in July 2009 for the treatment of group 1 pulmonary arterial hypertension. Inhaled treprostinil av...
Na minha lista:
| Udgivet i: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6116084/ https://ncbi.nlm.nih.gov/pubmed/30181846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622318779749 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|